SETBP1 and ETNK1 mutations are more common in aCML versus CNL, even though there are cases of aCML with CSF3R T618I mutations [75]; the presence of this mutation should make the pathologist pause and consider a CNL diagnosis. This evidence concerns the gene CSF3R and atypical chronic myeloid leukemia, BCR-ABL1 negative.